Management of the interaction between tacrolimus and nirmatrelvir/ritonavir in the treatment of COVID-19 in solid organ transplantation

被引：0
|
作者：
Leclerc, Vincent [1 ,3 ]
Sanctuaire, Alexandre [1 ]
Chateauvert, Nathalie [1 ,2 ]
机构：
[1] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Dept Pharm, Quebec City, PQ, Canada
[2] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Ctr Rech, Quebec City, PQ, Canada
[3] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin Se Foy, Quebec City, PQ G1V 4G5, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 76卷 / 03期
关键词：
D O I：
10.4212/cjhp.3352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：254 / 256
页数：3
相关论文
共 50 条
  • [21] Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
    Akinosoglou, Karolina
    Schinas, Georgios
    Gogos, Charalambos
    VIRUSES-BASEL, 2022, 14 (11):
  • [22] Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
    Kim, Haein
    Yang, Jeong-Sun
    Ko, Jae-Hoon
    Lee, Myungsun
    Lee, Joo-Yeon
    Park, Sehee
    Kim, Jun-Won
    Shin, Younmin
    Lee, Jung-Min
    Na, Yoo Jin
    Park, Byoung Kwon
    Kim, Hyungjin
    Lee, Young Ho
    Yang, Jinyoung
    Huh, Kyungmin
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19
    Tomida, Takeshi
    Itohara, Kotaro
    Yamamoto, Kazuhiro
    Kimura, Takeshi
    Fujita, Kohei
    Uda, Atsushi
    Kitahiro, Yumi
    Yokoyama, Naoki
    Hyodo, Yoji
    Omura, Tomohiro
    Yano, Ikuko
    DRUG METABOLISM AND PHARMACOKINETICS, 2023, 53
  • [24] Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews
    Cruciani, Mario
    Pati, Ilaria
    Masiello, Francesca
    Pupella, Simonetta
    De Angelis, Vincenzo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (03) : 477 - 497
  • [25] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
    LeBras, Marlys
    Crawley, Alex
    Legge, Marc
    Takaya, Satchan
    Lee, Stephen
    Regier, Loren
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
  • [26] Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
    Reis, Stefanie
    Metzendorf, Maria-Inti
    Kuehn, Rebecca
    Popp, Maria
    Gagyor, Ildiko
    Kranke, Peter
    Meybohm, Patrick
    Skoetz, Nicole
    Weibel, Stephanie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09): : CD015395
  • [27] Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19
    Reddy, Gangireddy Navitha
    Jogvanshi, Akanksha
    Naikwadi, Sana
    Sonti, Rajesh
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (09) : 943 - 955
  • [28] Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD
    Hiremath, Swapnil
    McGuinty, Michaeline
    Argyropoulos, Christos
    Brimble, K. Scott
    Brown, Pierre Antoine
    Chagla, Zain
    Cooper, Rebecca
    Hoar, Stephanie
    Juurlink, David
    Treleaven, Darin
    Walsh, Michael
    Yeung, Angie
    Blake, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (08): : 1247 - 1250
  • [29] VV116 or Nirmatrelvir- Ritonavir for Oral Treatment of Covid-19
    Lin, Dan-Yu
    Fleming, Thomas R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2395 - 2395
  • [30] New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19
    Atmar, Robert L.
    Finch, Natalie
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (08)
12345